These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 125811)

  • 1. [The effect of bromelain on fibrinolytic and antifibrinolytic enzyme systems (author's transl)].
    Miyatani K; Takahata J; Fukui I
    Rinsho Byori; 1975 Mar; 23(3):201-4. PubMed ID: 125811
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of elastase on fibrinolytic and antifibrinolytic enzyme systems (author's transl)].
    Miyatani K; Takahata J; Fukui I
    Rinsho Byori; 1975 Mar; 23(3):205-8. PubMed ID: 125812
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the standardization of fibrinolysis tests. II. Clinical significance of determination of fibrinolytic factors and its interpretation (author's transl)].
    Egawa H; Hashimoto S; Suzuki K
    Rinsho Byori; 1979 Mar; 27(3):250-6. PubMed ID: 155750
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assay of fibrinolytic factors with plasminogen-free bovine fibrin-agar-plate and its clinical application. I. Some properties of plate and features for estimation of fibrinolytic factors (author's transl)].
    Abe T; Kazama M; Satoh A; Suzuki J; Yamamoto S
    Rinsho Ketsueki; 1975 Oct; 16(10):946-52. PubMed ID: 128644
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of a fibrinolysis enzyme activator from commercial bromelain.
    Ako H; Cheung AH; Matsuura PK
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):157-67. PubMed ID: 7199897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of amniotic fluid fibrinolytic activity (author's transl)].
    Hernandez A; Parrilla JJ; Aznar J; Gilabert J; Estelles A
    Sangre (Barc); 1975; 20(2):108-12. PubMed ID: 124956
    [No Abstract]   [Full Text] [Related]  

  • 7. [Observation on urinary fibrinolytic activity in various renal disease (author's transl)].
    Shibata M; Yamamoto A; Kishi T; Shimizu K; Kobayashi K; Sakai H; Ohtaka M
    Nihon Jinzo Gakkai Shi; 1981 Mar; 23(3):349-57. PubMed ID: 6458716
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of ethanol and acetaldehyde on fibrinolytic system (examinations in vitro).
    Skrzydlewska E; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():163-73. PubMed ID: 6242841
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN; Kizim AI
    Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.
    Collen D
    Thromb Haemost; 1980 Jun; 43(2):77-89. PubMed ID: 6450468
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis inhibitors.
    Davis GL
    Clin Lab Sci; 1997; 10(4):212-8. PubMed ID: 10169620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemistry of the fibrinolytic enzyme system in man.
    Rickli EE
    Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516
    [No Abstract]   [Full Text] [Related]  

  • 13. [Euglobulin lysis time method (author's transl)].
    Kazama M
    Rinsho Byori; 1976 Apr; 24(4):316-20. PubMed ID: 132550
    [No Abstract]   [Full Text] [Related]  

  • 14. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic system in patients with nephrotic syndrome].
    Andreenko GV; Poliantseva LR; Smirnova TA; Podorol'skaia LV
    Ter Arkh; 1976; 40(2):89-99. PubMed ID: 135367
    [No Abstract]   [Full Text] [Related]  

  • 16. [The fibrin agar plate method (author's transl)].
    Fujita S
    Rinsho Byori; 1976 Apr; 24(4):312-5. PubMed ID: 132549
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolytic and plasmin inhibitor activities in normal subjects and patients with acute myocardial infarction (author's transl)].
    Tamura Y; Otsuka A; Sone K; Sakurai E; Ueda S; Niki T; Mori H
    Rinsho Byori; 1980 Sep; 28(9):903-6. PubMed ID: 6166776
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent progress in fibrinolysis.
    Mannucci PM; Minetti D; Mari D
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079
    [No Abstract]   [Full Text] [Related]  

  • 20. The susceptibility of plasma to activation of fibrinolysis.
    Stief TW
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):123-5. PubMed ID: 8457639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.